公司资料
PLUS THERAPEUTICS, Inc. 股价、新闻与催化剂
- 股票代码:
- PSTV
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
3.87 USD (+6.03%)
收盘价
最后更新: 2026年7月31日
37.7M USD
市值
股价为何变动
目前无法获取 PSTV 的收盘价变动背景。
公司概览
业务概览
PLUS Therapeutics is an oncology company focused on radiotherapeutics and targeted treatment delivery for cancer. Its story is built around the use of radiation-based approaches to address hard-to-treat tumors.
所在地与行业分类
PLUS Therapeutics is headquartered in the United States and listed on NASDAQ. It sits in small-cap oncology biotechnology.
商业模式特征
The company depends on clinical progress, regulatory steps, and the ability to prove its delivery strategy can improve cancer outcomes. Investors usually track readouts, manufacturing, and financing.
生物医药行业定位
PLUS Therapeutics occupies a niche radiotherapy position within biotech. The stock is catalyst-sensitive because its value depends on narrow oncology programs and execution.
未来催化剂
- PLUS Therapeutics’s catalysts are Rhenium-based oncology programs and any clinical or regulatory update that keeps the platform moving. The company remains highly dependent on proof of concept.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。